CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
NorDx, a member of MaineHealth, is the nation’s first clinical laboratory to acquire Sysmex America’s XN series automated hematology analyzers. The Sysmex XN-3000 configuration enables enhanced diagnostic capabilities and greater efficiency, which transforms NorDx into an accountable care laboratory model and shepherds in a new era of performance standards for quality care in New England, according to Stan Schofield, president of NorDx and senior VP of MaineHealth.
The Sysmex XN-3000 has advanced clinical parameters that allow NorDx and MaineHealth to conduct cellular studies that allow the quantitative assessments of red cell, white cell, and platelet precursors. These include NRBCs with every CBC, immature granulocytes with every differential, RET-He within the reticulocyte profile, and a fluorescent platelet channel for IPF to aid in the differential diagnosis of thrombocytopenia.
The Sysmex XN-3000 optimizes efficiency of workflow, staffing, and space and offers scalability and standardization across the enterprise to match the hospital’s current workflow, clinical parameters, and informatics needs.
Sysmex America, 800-462-1262